human garp (R&D Systems)
R&D Systems is a verified supplier 
R&D Systems manufactures this product 
92
Structured Review
R&D Systems
human garp
Human Garp, supplied by R&D Systems, used in various techniques. Bioz Stars score: 92/100, based on 5 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/human+garp/Recombinant+Human+LRRC32%2FGARP+Protein%2C+CF/us12006372-495-46-48
Average 92 stars, based on 5 article reviews
Human Garp, supplied by R&D Systems, used in various techniques. Bioz Stars score: 92/100, based on 5 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/human+garp/Recombinant+Human+LRRC32%2FGARP+Protein%2C+CF/us12006372-495-46-48
Average 92 stars, based on 5 article reviews
human garp - by Bioz Stars,
2026-09
92/100 stars
Images
Related Articles
Binding Assay:Article Title: Anti-garp antibody Article Snippet: The IgG of the 105F antibody or the 110F antibody was transiently expressed by inserting the above described IgG expression vector for animal cells into FreeStyle 293F cells (Life Technologies), and then the resulting IgGs were purified using a Protein A Affinity column (HiTrap Mab Select SuRe, GE Healthcare), as necessary. .. Thereafter, the buffer in which IgG was dissolved was replaced with PBS using Vivaspin 20 (7k MWCO, GE Healthcare) and the resultant was then subjected to the following step “1)-5.” 1)-5 Confirmation of Binding of Purified IgG to GARP According to ELISA 100 μL of Article Title: Anti-GARP antibody Article Snippet: The IgG of the 105F antibody or the 110F antibody was transiently expressed by inserting the above described IgG expression vector for animal cells into FreeStyle 293F cells (Life Technologies), and then the resulting IgGs were purified using a Protein A Affinity column (HiTrap Mab Select SuRe, GE Healthcare), as necessary. .. Thereafter, the buffer in which IgG was dissolved was replaced with PBS using Vivaspin 20 (7 k MWCO, GE Healthcare) and the resultant was then subjected to the following step “1)-5.” 1)-5 Confirmation of Binding of Purified IgG to GARP According to ELISA 100 μL of Purification:Article Title: Anti-garp antibody Article Snippet: The IgG of the 105F antibody or the 110F antibody was transiently expressed by inserting the above described IgG expression vector for animal cells into FreeStyle 293F cells (Life Technologies), and then the resulting IgGs were purified using a Protein A Affinity column (HiTrap Mab Select SuRe, GE Healthcare), as necessary. .. Thereafter, the buffer in which IgG was dissolved was replaced with PBS using Vivaspin 20 (7k MWCO, GE Healthcare) and the resultant was then subjected to the following step “1)-5.” 1)-5 Confirmation of Binding of Purified IgG to GARP According to ELISA 100 μL of Article Title: Anti-GARP antibody Article Snippet: The IgG of the 105F antibody or the 110F antibody was transiently expressed by inserting the above described IgG expression vector for animal cells into FreeStyle 293F cells (Life Technologies), and then the resulting IgGs were purified using a Protein A Affinity column (HiTrap Mab Select SuRe, GE Healthcare), as necessary. .. Thereafter, the buffer in which IgG was dissolved was replaced with PBS using Vivaspin 20 (7 k MWCO, GE Healthcare) and the resultant was then subjected to the following step “1)-5.” 1)-5 Confirmation of Binding of Purified IgG to GARP According to ELISA 100 μL of Enzyme-linked Immunosorbent Assay:Article Title: Anti-garp antibody Article Snippet: The IgG of the 105F antibody or the 110F antibody was transiently expressed by inserting the above described IgG expression vector for animal cells into FreeStyle 293F cells (Life Technologies), and then the resulting IgGs were purified using a Protein A Affinity column (HiTrap Mab Select SuRe, GE Healthcare), as necessary. .. Thereafter, the buffer in which IgG was dissolved was replaced with PBS using Vivaspin 20 (7k MWCO, GE Healthcare) and the resultant was then subjected to the following step “1)-5.” 1)-5 Confirmation of Binding of Purified IgG to GARP According to ELISA 100 μL of Article Title: Anti-GARP antibody Article Snippet: The IgG of the 105F antibody or the 110F antibody was transiently expressed by inserting the above described IgG expression vector for animal cells into FreeStyle 293F cells (Life Technologies), and then the resulting IgGs were purified using a Protein A Affinity column (HiTrap Mab Select SuRe, GE Healthcare), as necessary. .. Thereafter, the buffer in which IgG was dissolved was replaced with PBS using Vivaspin 20 (7 k MWCO, GE Healthcare) and the resultant was then subjected to the following step “1)-5.” 1)-5 Confirmation of Binding of Purified IgG to GARP According to ELISA 100 μL of Incubation:Article Title: Anti-garp antibody Article Snippet: The IgG of the 105F antibody or the 110F antibody was transiently expressed by inserting the above described IgG expression vector for animal cells into FreeStyle 293F cells (Life Technologies), and then the resulting IgGs were purified using a Protein A Affinity column (HiTrap Mab Select SuRe, GE Healthcare), as necessary. .. Thereafter, the buffer in which IgG was dissolved was replaced with PBS using Vivaspin 20 (7k MWCO, GE Healthcare) and the resultant was then subjected to the following step “1)-5.” 1)-5 Confirmation of Binding of Purified IgG to GARP According to ELISA 100 μL of Article Title: Anti-GARP antibody Article Snippet: The IgG of the 105F antibody or the 110F antibody was transiently expressed by inserting the above described IgG expression vector for animal cells into FreeStyle 293F cells (Life Technologies), and then the resulting IgGs were purified using a Protein A Affinity column (HiTrap Mab Select SuRe, GE Healthcare), as necessary. .. Thereafter, the buffer in which IgG was dissolved was replaced with PBS using Vivaspin 20 (7 k MWCO, GE Healthcare) and the resultant was then subjected to the following step “1)-5.” 1)-5 Confirmation of Binding of Purified IgG to GARP According to ELISA 100 μL of Recombinant:Article Title: Selective targeting of GARP-LTGFβ axis in the tumor microenvironment augments PD-1 blockade via enhancing CD8 + T cell antitumor immunity Article Snippet: .. BALB/c mice was immunized with recombinant Article Title: Selective targeting of GARP-LTGFβ axis in the tumor microenvironment augments PD-1 blockade via enhancing CD8 + T cell antitumor immunity. Article Snippet: .. Generation of Article Title: Methods for treatment and diagnosis of cancer by targeting glycoprotein A repetitions predominant (GARP) and for providing effective immunotherapy alone or in combination Article Snippet: .. Four BALB/c mice were immunized with recombinant Adjuvant:Article Title: Selective targeting of GARP-LTGFβ axis in the tumor microenvironment augments PD-1 blockade via enhancing CD8 + T cell antitumor immunity Article Snippet: .. BALB/c mice was immunized with recombinant Article Title: Selective targeting of GARP-LTGFβ axis in the tumor microenvironment augments PD-1 blockade via enhancing CD8 + T cell antitumor immunity. Article Snippet: .. Generation of Article Title: Methods for treatment and diagnosis of cancer by targeting glycoprotein A repetitions predominant (GARP) and for providing effective immunotherapy alone or in combination Article Snippet: .. Four BALB/c mice were immunized with recombinant Stable Transfection:Article Title: Methods for treatment and diagnosis of cancer by targeting glycoprotein A repetitions predominant (GARP) and for providing effective immunotherapy alone or in combination Article Snippet: .. Four BALB/c mice were immunized with recombinant Expressing:Article Title: Methods for treatment and diagnosis of cancer by targeting glycoprotein A repetitions predominant (GARP) and for providing effective immunotherapy alone or in combination Article Snippet: .. Four BALB/c mice were immunized with recombinant |
![Figure 6. GARP expression in GB is unaffected throughout therapy. (A) Survival analysis of GARP and CD133 based on data available through The Cancer Genome Atlas (TCGA). GARP and CD133 mRNA expression data of 152 primary glioblastomas were divided 50/50 into either “low” expres- sion or “high” expression and were analyzed for patient survival. (B) Retrospective analysis of transcriptomic data of 155 GB samples from 28 patients of Kim et al., 2020 [32]. ndGBs, first, and second recurrent tumors were analyzed for their GARP and CD133 mRNA levels across tumor stages. (C) Flow cytometric analysis of IT-619 and IT-654. Doublets, debris, and dead cells were excluded from analysis. Recurrent IT-654 GSCs exhibited stable surface GARP levels after TMZ and radiotherapy, whereas expression of CD133 decreased after treatment. The MFIs were normalized to the unstained control. n = 3. Significance was calculated by Student´s t-test and is indicated as follows: * p < 0.05, *** p < 0.001, and ns (not significant). (D) Number of GARP-positive nuclei for GSC IT-619 and IT-654 were analyzed by counting double-positive (Hoechst and GARP) cell nuclei. “No.” indicates the number of counted cells for the analysis.](https://pub-med-unpaywalled-images-cdn.bioz.com/pub_med_ids_ending_with_6258/pm38136258/pm38136258__page14_image1.jpg)
